Thyroid dysfunction and immune checkpoint inhibitor outcomes.

被引：0
|
作者：
von Itzstein, Mitchell S.
Lu, Rong
Ali, Sadia
Xie, Donglu
Cai, Jennifer
Xie, Yang
Gerber, David E.
机构：
[1] UT Southwestern, Dallas, TX USA
[2] UT Southwestern Med Ctr, Dallas, TX USA
[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15103
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Outcomes of immune-checkpoint inhibitor induced organ toxicities.
    Abu Sbeih, Hamzah
    Tang, Tenglong
    Johnson, Daniel H.
    Diab, Adi
    Wang, Yinghong
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] PREDICTORS AND OUTCOMES OF STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR HEPATITIS
    Li, Michael
    Sack, Jordan
    Rahma, Osama E.
    Grover, Shilpa
    Zucker, Stephen D.
    HEPATOLOGY, 2020, 72 : 85A - 85A
  • [43] OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN MALIGNANCY-ASSOCIATED DERMATOMYOSITIS
    Fernandez, D. R.
    Thaler, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 559 - 559
  • [44] Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction
    Michel, Lars
    Ferdinandy, Peter
    Rassaf, Tienush
    CURRENT HEART FAILURE REPORTS, 2024, 21 (03) : 214 - 223
  • [45] Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction
    Lars Michel
    Peter Ferdinandy
    Tienush Rassaf
    Current Heart Failure Reports, 2024, 21 : 214 - 223
  • [46] Immune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer
    Hayashi-Tanner, Yacki
    Polewski, Peter J.
    Gaddam, Mamatha
    Fisher, Nancy R.
    Kovacs, Attila J.
    Marinier, David E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) : 1011 - 1016
  • [47] Associations between psychosocial risk factors and immune checkpoint inhibitor outcomes
    Derry-Vick, Heather
    Zaemes, Jacob Peter
    Ahn, Jaeil
    Pascual, Lauren
    Sinclaire, Brittany
    Lev-Ari, Shaked
    Alaoui, Adil
    Sridhar, Aishwarya
    Adams, David
    Della Pia, Alexandra
    Pecora, Andrew L.
    Atkins, Michael B.
    Ip, Andrew
    Shah, Neil J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Incidence and outcomes of immune checkpoint inhibitor-related myositis.
    Aldrich, Jeffrey
    Pundole, Xerxes
    Tummala, Sudhakar
    Andersen, Clark
    Shoukier, Mahran
    Abdel-Wahab, Noha
    Palaskas, Nicolas
    Deswal, Anita
    Suarez-Almazor, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma
    Fletcher, Kylie
    Rehman, Saba
    Irlmeier, Rebecca
    Ye, Fei
    Johnson, Douglas
    ONCOLOGIST, 2024,
  • [50] Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes
    Dow, Eliot R.
    Yung, Madeline
    Tsui, Edmund
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) : 203 - 211
12345